Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acetaminophen hepatotoxicity: the first 35 years.

Barry H Rumack1

  • 1University of Colorado School of Medicine and Rocky Mountain Poison and Drug Center, Denver, USA. barry@rumack.com

Journal of Toxicology. Clinical Toxicology
|May 7, 2002
PubMed
Summary

Acetaminophen toxicity is complex, influenced by cytochrome P450 enzyme variations. Understanding these interactions is crucial for safe acetaminophen use, even with enzyme inducers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Out-of-hospital assessment and triage of paracetamol (acetaminophen) exposure in the United States and Canada: a consensus guideline.

Clinical toxicology (Philadelphia, Pa.)·2025
Same author

Clinically relevant therapeutic approaches against acetaminophen hepatotoxicity and acute liver failure.

Biochemical pharmacology·2024
Same author

Fifty years of paracetamol (acetaminophen) poisoning: the development of risk assessment and treatment 1973-2023 with particular focus on contributions published from Edinburgh and Denver.

Clinical toxicology (Philadelphia, Pa.)·2024
Same author

Lack of mitochondrial Cyp2E1 drives acetaminophen-induced ER stress-mediated apoptosis in mouse and human kidneys: Inhibition by 4-methylpyrazole but not N-acetylcysteine.

Toxicology·2023
Same author

Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement.

JAMA network open·2023
Same author

Failure of Risk Assessment After Paracetamol Overdose-A Short Communication.

Therapeutic drug monitoring·2022

Area of Science:

  • Pharmacology
  • Toxicology
  • Biochemistry

Background:

  • The cytochrome P450 (CYP450) system's complexity and genetic variability in drug metabolism are increasingly understood.
  • Early research often treated the CYP450 system as a single entity, leading to oversimplified conclusions about drug interactions.

Discussion:

  • The role of CYP2E1, influenced by diet and ethanol, is critical in acetaminophen metabolism and toxicity.
  • Induction of CYP450 by substances like barbiturates and anticonvulsants does not uniformly increase acetaminophen toxicity.
  • Phenytoin's potential to reduce, rather than enhance, acetaminophen toxicity highlights the evolving understanding of these interactions.

Key Insights:

  • Therapeutic doses of acetaminophen are not toxic, even when co-administered with CYP450 inducers.
  • Misleading terminology like "therapeutic misadventure" can obscure the scientific understanding of drug toxicity.
  • Genetic variability and specific enzyme activity (e.g., CYP2E1) are key determinants of acetaminophen toxicity.

Outlook:

  • Further education is needed for non-toxicologists to grasp the scientific nuances of acetaminophen metabolism and safety.
  • Continued research into CYP450 genetic polymorphisms will refine our understanding of individual susceptibility to drug toxicity.
  • Accurate scientific communication is vital to prevent misinterpretations of drug-induced toxicity data.

Related Experiment Videos